Streetbeat News

NMTC

NeuroOne Medical Technologies Corporation

Industry

Medical - Devices

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Open

0.74

Mkt cap

23M

Volume

26K

High

0.78

P/E Ratio

-1.61

52-wk high

1.72

Low

0.74

Div yield

N/A

52-wk low

0.55

NeuroOne Medical Technologies Corporation (NMTC) held its Q4 2024 earnings call, discussing financial results and company performance.

Portfolio Pulse from

December 17, 2024 | 3:00 pm

NeuroOne's product revenue increased by 77% to $3.5 million in fiscal 2024, with expectations to grow by at least 132% to $8 million in fiscal 2025. The company's exclusive distribution agreement with Zimmer Biomet, which included a $3 million upfront payment, is expected to drive revenue and expand margins significantly.

Portfolio Pulse from

December 17, 2024 | 1:45 pm

NeuroOne Medical Technologies, a small-cap medical device company, is gaining attention due to its FDA-cleared electrodes used in epilepsy treatment. Partnered with Zimmer Biomet, NMTC is nearing cash flow break-even, potentially reducing shareholder dilution.

Portfolio Pulse from

December 10, 2024 | 8:30 am

NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) will present at the Virtual Investor Summit Microcap Event on November 21st, 2024. The company will also be available for 1-on-1 meetings.

Portfolio Pulse from

November 13, 2024 | 2:45 pm

NeuroOne Medical Technologies Corporation has expanded its distribution agreement with Zimmer Biomet, granting Zimmer Biomet exclusive rights to distribute NeuroOne's OneRF Ablation System in the U.S. and certain international markets. NeuroOne will receive a $3 million upfront payment, and the agreement is expected to enhance the company's sales revenue and profitability.